{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T23:50:32Z","timestamp":1773273032789,"version":"3.50.1"},"reference-count":87,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T00:00:00Z","timestamp":1772755200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T00:00:00Z","timestamp":1773187200000},"content-version":"vor","delay-in-days":5,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Funding for this project was provided by an investigator-initiated contract from Millennium Pharmaceuticals (awarded to D.A.P)."}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Transl Psychiatry"],"DOI":"10.1038\/s41398-026-03928-4","type":"journal-article","created":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T14:25:56Z","timestamp":1772807156000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Modulatory effects of ketamine on EEG source-based resting state connectivity in treatment resistant depression"],"prefix":"10.1038","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7321-2704","authenticated-orcid":false,"given":"Ty","family":"Lees","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"suffix":"Jr","given":"Jason N.","family":"Scott","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brian W.","family":"Boyle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shiba M.","family":"Esfand","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samantha R.","family":"Linton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Courtney","family":"Miller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-6615-8077","authenticated-orcid":false,"given":"Mohan","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6517-4106","authenticated-orcid":false,"given":"Sarah E.","family":"Woronko","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rebecca","family":"Dunayev","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2386-3557","authenticated-orcid":false,"given":"Mario","family":"Bogdanov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paula","family":"Bolton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuang","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert C.","family":"Meisner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7772-1143","authenticated-orcid":false,"given":"Diego A.","family":"Pizzagalli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,3,6]]},"reference":[{"key":"3928_CR1","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1016\/S0140-6736(21)02141-3","volume":"399","author":"H Herrman","year":"2022","unstructured":"Herrman H, Patel V, Kieling C, Berk M, Buchweitz C, Cuijpers P, et al. Time for united action on depression: A Lancet\u2013World Psychiatric Association Commission. The Lancet. 2022;399:957\u20131022.","journal-title":"The Lancet"},{"key":"3928_CR2","doi-asserted-by":"publisher","DOI":"10.1176\/appi.books.9780890425596","volume-title":"Diagnostic and Statistical Manual of Mental Disorders","author":"American Psychiatric Association","year":"2013","unstructured":"American Psychiatric Association Diagnostic and Statistical Manual of Mental Disorders. 5th ed.. American Psychiatric Association; 2013.","edition":"5th ed."},{"key":"3928_CR3","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.1177\/0269881119872194","volume":"33","author":"RW Taylor","year":"2019","unstructured":"Taylor RW, Marwood L, Greer B, Strawbridge R, Cleare AJ. Predictors of response to augmentation treatment in patients with treatment-resistant depression: A systematic review. J Psychopharmacol. 2019;33:1323\u201339.","journal-title":"J Psychopharmacol"},{"key":"3928_CR4","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1002\/da.22968","volume":"37","author":"BN Gaynes","year":"2020","unstructured":"Gaynes BN, Lux L, Gartlehner G, Asher G, Forman-Hoffman V, Green J, et al. Defining treatment-resistant depression. Depress Anxiety. 2020;37:134\u201345.","journal-title":"Depress Anxiety"},{"key":"3928_CR5","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1002\/wps.21120","volume":"22","author":"RS McIntyre","year":"2023","unstructured":"McIntyre RS, Alsuwaidan M, Baune BT, Berk M, Demyttenaere K, Goldberg JF, et al. Treatment-resistant depression: definition, prevalence, detection, management, and investigational interventions. World Psychiatry. 2023;22:394\u2013412.","journal-title":"World Psychiatry"},{"key":"3928_CR6","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/j.jad.2018.06.045","volume":"242","author":"KM Johnston","year":"2019","unstructured":"Johnston KM, Powell LC, Anderson IM, Szabo S, Cline S. The burden of treatment-resistant depression: A systematic review of the economic and quality of life literature. J Affect Disord. 2019;242:195\u2013210.","journal-title":"J Affect Disord"},{"key":"3928_CR7","doi-asserted-by":"publisher","first-page":"20m13699","DOI":"10.4088\/JCP.20m13699","volume":"82","author":"M Zhdanava","year":"2021","unstructured":"Zhdanava M, Pilon D, Ghelerter I, Chow W, Joshi K, Lefebvre P, et al. The prevalence and national burden of treatment-resistant depression and major depressive disorder in the United States. J Clin Psychiatry. 2021;82:20m13699.","journal-title":"J Clin Psychiatry"},{"key":"3928_CR8","doi-asserted-by":"publisher","first-page":"2475","DOI":"10.1185\/03007995.2010.517716","volume":"26","author":"JI Ivanova","year":"2010","unstructured":"Ivanova JI, Birnbaum HG, Kidolezi Y, Subramanian G, Khan SA, Stensland MD. Direct and indirect costs of employees with treatment-resistant and non-treatment-resistant major depressive disorder. Curr Med Res Opin. 2010;26:2475\u201384.","journal-title":"Curr Med Res Opin"},{"key":"3928_CR9","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1016\/S2215-0366(22)00317-0","volume":"9","author":"SY Smith-Apeldoorn","year":"2022","unstructured":"Smith-Apeldoorn SY, Veraart JK, Spijker J, Kamphuis J, Schoevers RA. Maintenance ketamine treatment for depression: a systematic review of efficacy, safety, and tolerability. Lancet Psychiatry. 2022;9:907\u201321.","journal-title":"Lancet Psychiatry"},{"key":"3928_CR10","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1176\/appi.ajp.2020.20081251","volume":"178","author":"RS McIntyre","year":"2021","unstructured":"McIntyre RS, Rosenblat JD, Nemeroff CB, Sanacora G, Murrough JW, Berk M, et al. Synthesizing the evidence for ketamine and esketamine in treatment-resistant depression: An international expert opinion on the available evidence and implementation. Am J Psychiatry. 2021;178:383\u201399.","journal-title":"Am J Psychiatry"},{"key":"3928_CR11","doi-asserted-by":"publisher","first-page":"247054701774351","DOI":"10.1177\/2470547017743511","volume":"1","author":"LR Aleksandrova","year":"2017","unstructured":"Aleksandrova LR, Wang YT, Phillips AG. Hydroxynorketamine: Implications for the NMDA receptor hypothesis of ketamine\u2019s antidepressant action. Chronic Stress. 2017;1:2470547017743511.","journal-title":"Chronic Stress"},{"key":"3928_CR12","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1016\/j.tips.2021.08.003","volume":"42","author":"LR Aleksandrova","year":"2021","unstructured":"Aleksandrova LR, Phillips AG. Neuroplasticity as a convergent mechanism of ketamine and classical psychedelics. Trends Pharmacol Sci. 2021;42:929\u201342.","journal-title":"Trends Pharmacol Sci"},{"key":"3928_CR13","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.neuropharm.2015.07.028","volume":"100","author":"OH Miller","year":"2016","unstructured":"Miller OH, Moran JT, Hall BJ. Two cellular hypotheses explaining the initiation of ketamine\u2019s antidepressant actions: Direct inhibition and disinhibition. Neuropharmacology. 2016;100:17\u201326.","journal-title":"Neuropharmacology"},{"key":"3928_CR14","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1146\/annurev-med-053013-062946","volume":"66","author":"CG Abdallah","year":"2015","unstructured":"Abdallah CG, Sanacora G, Duman RS, Krystal JH. Ketamine and rapid-acting antidepressants: A window into a new neurobiology for mood disorder therapeutics. Annu Rev Med. 2015;66:509\u201323.","journal-title":"Annu Rev Med"},{"key":"3928_CR15","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1016\/j.biopsych.2007.05.028","volume":"63","author":"S Maeng","year":"2008","unstructured":"Maeng S, Zarate CA, Du J, Schloesser RJ, McCammon J, Chen G, et al. Cellular mechanisms underlying the antidepressant effects of ketamine: role of \u03b1-Amino-3-Hydroxy-5-Methylisoxazole-4-Propionic acid receptors. Biol Psychiatry. 2008;63:349\u201352.","journal-title":"Biol Psychiatry"},{"key":"3928_CR16","doi-asserted-by":"publisher","first-page":"1336","DOI":"10.1172\/JCI130808","volume":"130","author":"DM Gerhard","year":"2020","unstructured":"Gerhard DM, Pothula S, Liu R-J, Wu M, Li X-Y, Girgenti MJ, et al. GABA interneurons are the cellular trigger for ketamine\u2019s rapid antidepressant actions. J Clin Invest. 2020;130:1336\u201349.","journal-title":"J Clin Invest"},{"key":"3928_CR17","doi-asserted-by":"publisher","first-page":"1150","DOI":"10.1176\/appi.ajp.2012.12040531","volume":"169","author":"ET Kavalali","year":"2012","unstructured":"Kavalali ET, Monteggia LM. Synaptic mechanisms underlying rapid antidepressant action of ketamine. Am J Psychiatry. 2012;169:1150\u20136.","journal-title":"Am J Psychiatry"},{"key":"3928_CR18","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1038\/nm.4050","volume":"22","author":"RS Duman","year":"2016","unstructured":"Duman RS, Aghajanian GK, Sanacora G, Krystal JH. Synaptic plasticity and depression: new insights from stress and rapid-acting antidepressants. Nat Med. 2016;22:238\u201349.","journal-title":"Nat Med"},{"key":"3928_CR19","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1097\/YCO.0000000000000222","volume":"29","author":"G Northoff","year":"2016","unstructured":"Northoff G. How do resting state changes in depression translate into psychopathological symptoms? From \u2018Spatiotemporal correspondence\u2019 to \u2018Spatiotemporal Psychopathology\u2019. Curr Opin Psychiatry. 2016;29:18\u201324.","journal-title":"Curr Opin Psychiatry"},{"key":"3928_CR20","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1001\/jamapsychiatry.2015.0071","volume":"72","author":"RH Kaiser","year":"2015","unstructured":"Kaiser RH, Andrews-Hanna JR, Wager TD, Pizzagalli DA. Large-Scale network dysfunction in major depressive disorder. JAMA Psychiatry. 2015;72:603.","journal-title":"JAMA Psychiatry"},{"key":"3928_CR21","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1016\/j.tics.2011.08.003","volume":"15","author":"V Menon","year":"2011","unstructured":"Menon V. Large-scale brain networks and psychopathology: a unifying triple network model. Trends Cogn Sci. 2011;15:483\u2013506.","journal-title":"Trends Cogn Sci"},{"key":"3928_CR22","doi-asserted-by":"publisher","first-page":"854","DOI":"10.1016\/j.jad.2015.05.007","volume":"190","author":"G Northoff","year":"2016","unstructured":"Northoff G. Spatiotemporal psychopathology I: No rest for the brain\u2019s resting state activity in depression? Spatiotemporal psychopathology of depressive symptoms. J Affect Disord. 2016;190:854\u201366.","journal-title":"J Affect Disord"},{"key":"3928_CR23","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1016\/j.neubiorev.2021.12.008","volume":"132","author":"Runia","year":"2022","unstructured":"Runia, Y\u00fccel DE N, Lok A, de Jong K, Denys DAJP, van Wingen GA, et al. The neurobiology of treatment-resistant depression: A systematic review of neuroimaging studies. Neurosci Biobehav Rev. 2022;132:433\u201348.","journal-title":"Neurosci Biobehav Rev"},{"key":"3928_CR24","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1016\/j.psc.2023.02.009","volume":"46","author":"MM Grehl","year":"2023","unstructured":"Grehl MM, Hameed S, Murrough JW. Brain features of treatment-resistant depression. Psychiatric Clinics of North America. 2023;46:391\u2013401.","journal-title":"Psychiatric Clinics of North America"},{"key":"3928_CR25","doi-asserted-by":"publisher","unstructured":"Siegel JS, Palanca BJA, Ances BM, Kharasch ED, Schweiger JA, Yingling MD, et al. Prolonged ketamine infusion modulates limbic connectivity and induces sustained remission of treatment-resistant depression. Psychopharmacology (Berl). 2021. 22 January 2021. https:\/\/doi.org\/10.1007\/s00213-021-05762-6.","DOI":"10.1007\/s00213-021-05762-6"},{"key":"3928_CR26","doi-asserted-by":"publisher","DOI":"10.1016\/j.pnpbp.2022.110621","volume":"120","author":"J Sun","year":"2023","unstructured":"Sun J, Ma Y, Guo C, Du Z, Chen L, Wang Z, et al. Distinct patterns of functional brain network integration between treatment-resistant depression and non treatment-resistant depression: A resting-state functional magnetic resonance imaging study. Prog Neuropsychopharmacol Biol Psychiatry. 2023;120:110621.","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"3928_CR27","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1176\/appi.ajp.2010.10101419","volume":"168","author":"S Lui","year":"2011","unstructured":"Lui S, Wu Q, Qiu L, Yang X, Kuang W, Chan RCK, et al. Resting-State functional connectivity in treatment-resistant depression. Am J Psychiatry. 2011;168:642\u20138.","journal-title":"Am J Psychiatry"},{"key":"3928_CR28","doi-asserted-by":"publisher","DOI":"10.1016\/j.nicl.2022.102990","volume":"34","author":"AR Barreiros","year":"2022","unstructured":"Barreiros AR, Breukelaar I, Mayur P, Andepalli J, Tomimatsu Y, Funayama K, et al. Abnormal habenula functional connectivity characterizes treatment-resistant depression. Neuroimage Clin. 2022;34:102990.","journal-title":"Neuroimage Clin"},{"key":"3928_CR29","doi-asserted-by":"publisher","DOI":"10.1016\/j.pnpbp.2021.110346","volume":"111","author":"S Amiri","year":"2021","unstructured":"Amiri S, Arbabi M, Kazemi K, Parvaresh-Rizi M, Mirbagheri MM. Characterization of brain functional connectivity in treatment-resistant depression. Prog Neuropsychopharmacol Biol Psychiatry. 2021;111:110346.","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"3928_CR30","doi-asserted-by":"publisher","first-page":"e45263","DOI":"10.1371\/journal.pone.0045263","volume":"7","author":"C Ma","year":"2012","unstructured":"Ma C, Ding J, Li J, Guo W, Long Z, Liu F, et al. Resting-State functional connectivity bias of middle temporal gyrus and caudate with altered gray matter volume in major depression. PLoS ONE. 2012;7:e45263.","journal-title":"PLoS ONE"},{"key":"3928_CR31","first-page":"361","volume":"8","author":"A Zavaliangos-Petropulu","year":"2023","unstructured":"Zavaliangos-Petropulu A, Al-Sharif NB, Taraku B, Leaver AM, Sahib AK, Espinoza RT, et al. Neuroimaging-Derived biomarkers of the antidepressant effects of ketamine. Biol Psychiatry Cogn Neurosci Neuroimaging. 2023;8:361\u201386.","journal-title":"Biol Psychiatry Cogn Neurosci Neuroimaging"},{"key":"3928_CR32","doi-asserted-by":"publisher","DOI":"10.1016\/j.psychres.2024.116092","volume":"340","author":"J-Y Yun","year":"2024","unstructured":"Yun J-Y, Kim Y-K. Neural correlates of treatment response to ketamine for treatment-resistant depression: A systematic review of MRI-based studies. Psychiatry Res. 2024;340:116092.","journal-title":"Psychiatry Res"},{"key":"3928_CR33","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1016\/S2215-0366(23)00183-9","volume":"10","author":"GC Medeiros","year":"2023","unstructured":"Medeiros GC, Matheson M, Demo I, Reid MJ, Matheson S, Twose C, et al. Brain-based correlates of antidepressant response to ketamine: a comprehensive systematic review of neuroimaging studies. Lancet Psychiatry. 2023;10:790\u2013800.","journal-title":"Lancet Psychiatry"},{"key":"3928_CR34","doi-asserted-by":"publisher","DOI":"10.1038\/s41398-024-03180-8","volume":"14","author":"GC Medeiros","year":"2024","unstructured":"Medeiros GC, Demo I, Goes FS, Zarate CA, Gould TD. Personalized use of ketamine and esketamine for treatment-resistant depression. Transl Psychiatry. 2024;14:481.","journal-title":"Transl Psychiatry"},{"key":"3928_CR35","doi-asserted-by":"publisher","first-page":"1210","DOI":"10.1038\/npp.2016.186","volume":"42","author":"CG Abdallah","year":"2017","unstructured":"Abdallah CG, Averill LA, Collins KA, Geha P, Schwartz J, Averill C, et al. Ketamine treatment and global brain connectivity in major depression. Neuropsychopharmacology. 2017;42:1210\u20139.","journal-title":"Neuropsychopharmacology"},{"key":"3928_CR36","doi-asserted-by":"publisher","first-page":"247054701879610","DOI":"10.1177\/2470547018796102","volume":"2","author":"CG Abdallah","year":"2018","unstructured":"Abdallah CG, Dutta A, Averill CL, McKie S, Akiki TJ, Averill LA, et al. Ketamine, but not the NMDAR antagonist lanicemine, increases prefrontal global connectivity in depressed patients. Chronic Stress. 2018;2:2470547018796102.","journal-title":"Chronic Stress"},{"key":"3928_CR37","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1038\/s41386-020-00864-9","volume":"46","author":"CG Abdallah","year":"2021","unstructured":"Abdallah CG, Ahn K-H, Averill LA, Nemati S, Averill CL, Fouda S, et al. A robust and reproducible connectome fingerprint of ketamine is highly associated with the connectomic signature of antidepressants. Neuropsychopharmacology. 2021;46:478\u201385.","journal-title":"Neuropsychopharmacology"},{"key":"3928_CR38","doi-asserted-by":"publisher","first-page":"e84173","DOI":"10.7554\/eLife.84173","volume":"13","author":"F Moujaes","year":"2024","unstructured":"Moujaes F, Ji JL, Rahmati M, Burt JB, Schleifer C, Adkinson BD, et al. Ketamine induces multiple individually distinct whole-brain functional connectivity signatures. eLife. 2024;13:e84173.","journal-title":"eLife"},{"key":"3928_CR39","doi-asserted-by":"publisher","first-page":"3292","DOI":"10.1038\/s41380-020-00878-1","volume":"26","author":"A Mkrtchian","year":"2021","unstructured":"Mkrtchian A, Evans JW, Kraus C, Yuan P, Kadriu B, Nugent AC, et al. Ketamine modulates fronto-striatal circuitry in depressed and healthy individuals. Mol Psychiatry. 2021;26:3292\u2013301.","journal-title":"Mol Psychiatry"},{"key":"3928_CR40","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1016\/j.biopsych.2018.01.027","volume":"84","author":"JW Evans","year":"2018","unstructured":"Evans JW, Szczepanik J, Brutsch\u00e9 N, Park LT, Nugent AC, Zarate CA. Default mode connectivity in major depressive disorder measured up to 10 days after ketamine administration. Biol Psychiatry. 2018;84:582\u201390.","journal-title":"Biol Psychiatry"},{"key":"3928_CR41","doi-asserted-by":"publisher","first-page":"982","DOI":"10.1038\/s41386-020-0624-0","volume":"45","author":"C Kraus","year":"2020","unstructured":"Kraus C, Mkrtchian A, Kadriu B, Nugent AC, Zarate CA, Evans JW. Evaluating global brain connectivity as an imaging marker for depression: influence of preprocessing strategies and placebo-controlled ketamine treatment. Neuropsychopharmacology. 2020;45:982\u20139.","journal-title":"Neuropsychopharmacology"},{"key":"3928_CR42","doi-asserted-by":"publisher","first-page":"13170","DOI":"10.1073\/pnas.0700668104","volume":"104","author":"D Mantini","year":"2007","unstructured":"Mantini D, Perrucci MG, Del Gratta C, Romani GL, Corbetta M. Electrophysiological signatures of resting state networks in the human brain. Proc Natl Acad Sci. 2007;104:13170\u20135.","journal-title":"Proc Natl Acad Sci"},{"key":"3928_CR43","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1016\/j.neuroimage.2013.01.049","volume":"72","author":"C Chang","year":"2013","unstructured":"Chang C, Liu Z, Chen MC, Liu X, Duyn JH. EEG correlates of time-varying BOLD functional connectivity. Neuroimage. 2013;72:227\u201336.","journal-title":"Neuroimage"},{"key":"3928_CR44","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.pscychresns.2016.06.006","volume":"254","author":"AC Nugent","year":"2016","unstructured":"Nugent AC, Robinson SE, Coppola R, Zarate CA. Preliminary differences in resting state MEG functional connectivity pre- and post-ketamine in major depressive disorder. Psychiatry Res Neuroimaging. 2016;254:56\u201366.","journal-title":"Psychiatry Res Neuroimaging"},{"key":"3928_CR45","doi-asserted-by":"publisher","first-page":"519","DOI":"10.3389\/fpsyt.2020.00519","volume":"11","author":"AC Nugent","year":"2020","unstructured":"Nugent AC, Ballard ED, Gilbert JR, Tewarie PK, Brookes MJ, Zarate CA. The effect of ketamine on electrophysiological connectivity in major depressive disorder. Front Psychiatry. 2020;11:519.","journal-title":"Front Psychiatry"},{"key":"3928_CR46","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1159\/000525338","volume":"81","author":"S Minami","year":"2022","unstructured":"Minami S, Kato M, Ikeda S, Yoshimura M, Ueda S, Koshikawa Y, et al. Association between the rostral anterior cingulate cortex and anterior insula in the salience network on response to antidepressants in major depressive disorder as revealed by isolated effective coherence. Neuropsychobiology. 2022;81:475\u201383.","journal-title":"Neuropsychobiology"},{"key":"3928_CR47","first-page":"45","volume":"5","author":"RL Sumner","year":"2020","unstructured":"Sumner RL, McMillan R, Spriggs MJ, Campbell D, Malpas G, Maxwell E, et al. Ketamine enhances visual sensory evoked potential long-term potentiation in patients with major depressive disorder. Biol Psychiatry Cogn Neurosci Neuroimaging. 2020;5:45\u201355.","journal-title":"Biol Psychiatry Cogn Neurosci Neuroimaging"},{"key":"3928_CR48","doi-asserted-by":"publisher","DOI":"10.1038\/s41398-024-02738-w","volume":"14","author":"RL Sumner","year":"2024","unstructured":"Sumner RL, McMillan RL, Forsyth A, Muthukumaraswamy SD, Shaw AD. Neurophysiological evidence that frontoparietal connectivity and GABA-A receptor changes underpin the antidepressant response to ketamine. Transl Psychiatry. 2024;14:116.","journal-title":"Transl Psychiatry"},{"key":"3928_CR49","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1001\/jamapsychiatry.2019.3867","volume":"77","author":"CE Rolle","year":"2020","unstructured":"Rolle CE, Fonzo GA, Wu W, Toll R, Jha MK, Cooper C, et al. Cortical connectivity moderators of antidepressant vs placebo treatment response in major depressive disorder. JAMA Psychiatry. 2020;77:397.","journal-title":"JAMA Psychiatry"},{"key":"3928_CR50","doi-asserted-by":"publisher","first-page":"872","DOI":"10.1016\/j.biopsych.2018.12.007","volume":"85","author":"AE Whitton","year":"2019","unstructured":"Whitton AE, Webb CA, Dillon DG, Kayser J, Rutherford A, Goer F, et al. Pretreatment rostral anterior cingulate cortex connectivity with salience network predicts depression recovery: Findings from the EMBARC randomized clinical trial. Biol Psychiatry. 2019;85:872\u201380.","journal-title":"Biol Psychiatry"},{"key":"3928_CR51","doi-asserted-by":"publisher","first-page":"1469645","DOI":"10.3389\/fpsyt.2024.1469645","volume":"15","author":"K-M Choi","year":"2024","unstructured":"Choi K-M, Lee T, Im C-H, Lee S-H. Prediction of pharmacological treatment efficacy using electroencephalography-based salience network in patients with major depressive disorder. Front Psychiatry. 2024;15:1469645.","journal-title":"Front Psychiatry"},{"key":"3928_CR52","doi-asserted-by":"publisher","DOI":"10.1016\/j.pnpbp.2019.109838","volume":"99","author":"R McMillan","year":"2020","unstructured":"McMillan R, Sumner R, Forsyth A, Campbell D, Malpas G, Maxwell E, et al. Simultaneous EEG\/fMRI recorded during ketamine infusion in patients with major depressive disorder. Prog Neuropsychopharmacol Biol Psychiatry. 2020;99:109838.","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"3928_CR53","doi-asserted-by":"publisher","first-page":"1233","DOI":"10.1038\/s41386-019-0317-8","volume":"44","author":"ST Wilkinson","year":"2019","unstructured":"Wilkinson ST, Farmer C, Ballard ED, Mathew SJ, Grunebaum MF, Murrough JW, et al. Impact of midazolam vs. saline on effect size estimates in controlled trials of ketamine as a rapid-acting antidepressant. Neuropsychopharmacology. 2019;44:1233\u20138.","journal-title":"Neuropsychopharmacology"},{"key":"3928_CR54","first-page":"22","volume":"59","author":"DV Sheehan","year":"1998","unstructured":"Sheehan DV, Lecrubier Y, Sheehan KH, Amorim P, Janavs J, Weiller E, et al. The Mini-International Neuropsychiatric Interview (M.I.N.I.): The development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry. 1998;59:22\u201333.","journal-title":"J Clin Psychiatry"},{"key":"3928_CR55","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1136\/jnnp.23.1.56","volume":"23","author":"M Hamilton","year":"1960","unstructured":"Hamilton M. A rating scale for Depression. J Neurol Neurosurg Psychiatry. 1960;23:56\u201362.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"3928_CR56","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1016\/S0006-3223(02)01866-8","volume":"54","author":"AJ Rush","year":"2003","unstructured":"Rush AJ, Trivedi MH, Ibrahim HM, Carmody TJ, Arnow B, Klein DN, et al. The 16-Item quick inventory of depressive symptomatology (QIDS), clinician rating (QIDS-C), and self-report (QIDS-SR): a psychometric evaluation in patients with chronic major depression. Biol Psychiatry. 2003;54:573\u201383.","journal-title":"Biol Psychiatry"},{"key":"3928_CR57","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1037\/0021-843X.100.3.316","volume":"100","author":"LA Clark","year":"1991","unstructured":"Clark LA, Watson D. Tripartite model of anxiety and depression: Psychometric evidence and taxonomic implications. J Abnorm Psychol. 1991;100:316\u201336.","journal-title":"J Abnorm Psychol"},{"key":"3928_CR58","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1192\/bjp.167.1.99","volume":"167","author":"RP Snaith","year":"1995","unstructured":"Snaith RP, Hamilton M, Morley S, Humayan A, Hargreaves D, Trigwell P. A scale for the assessment of hedonic tone the Snaith\u2013Hamilton pleasure scale. Br J Psychiatry. 1995;167:99\u2013103.","journal-title":"Br J Psychiatry"},{"key":"3928_CR59","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1037\/0022-3514.61.1.115","volume":"61","author":"S Nolen-Hoeksema","year":"1991","unstructured":"Nolen-Hoeksema S, Morrow J. A prospective study of depression and posttraumatic stress symptoms after a natural disaster: The 1989 Loma Prieta earthquake. J Pers Soc Psychol. 1991;61:115\u201321.","journal-title":"J Pers Soc Psychol"},{"key":"3928_CR60","first-page":"50","volume":"3","author":"AE Whitton","year":"2018","unstructured":"Whitton AE, Deccy S, Ironside ML, Kumar P, Beltzer M, Pizzagalli DA. Electroencephalography source functional connectivity reveals abnormal high-frequency communication among large-scale functional networks in depression. Biol Psychiatry Cogn Neurosci Neuroimaging. 2018;3:50\u20138.","journal-title":"Biol Psychiatry Cogn Neurosci Neuroimaging"},{"key":"3928_CR61","doi-asserted-by":"publisher","DOI":"10.1016\/j.bpsgos.2025.100602","volume":"5","author":"T Lees","year":"2025","unstructured":"Lees T, Woronko SE, Li M, Scott JN, Kuhn M, Esfand SM, et al. Differences in high-frequency connectivity among large-scale functional networks linked to major depressive disorder and treatment-resistant depression. Biol Psychiatry Global Open Sci. 2025;5:100602.","journal-title":"Biol Psychiatry Global Open Sci"},{"key":"3928_CR62","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1016\/0013-4694(89)90180-6","volume":"72","author":"F Perrin","year":"1989","unstructured":"Perrin F, Pernier J, Bertrand O, Echallier JF. Spherical splines for scalp potential and current density mapping. Electroencephalogr Clin Neurophysiol. 1989;72:184\u20137.","journal-title":"Electroencephalogr Clin Neurophysiol"},{"key":"3928_CR63","doi-asserted-by":"publisher","first-page":"3768","DOI":"10.1098\/rsta.2011.0081","volume":"369","author":"RD Pascual-Marqui","year":"2011","unstructured":"Pascual-Marqui RD, Lehmann D, Koukkou M, Kochi K, Anderer P, Saletu B, et al. Assessing interactions in the brain with exact low-resolution electromagnetic tomography. Philos Trans Royal Soc A: Math Phys Eng Sci. 2011;369:3768\u201384.","journal-title":"Philos Trans Royal Soc A: Math Phys Eng Sci"},{"key":"3928_CR64","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1016\/S1388-2457(02)00030-5","volume":"113","author":"M Fuchs","year":"2002","unstructured":"Fuchs M, Kastner J, Wagner M, Hawes S, Ebersole JS. A standardized boundary element method volume conductor model. Clin Neurophysiol. 2002;113:702\u201312.","journal-title":"Clin Neurophysiol"},{"key":"3928_CR65","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.1098\/rstb.2001.0915","volume":"356","author":"J Mazziotta","year":"2001","unstructured":"Mazziotta J, Toga A, Evans A, Fox P, Lancaster J, Zilles K, et al. A probabilistic atlas and reference system for the human brain: International Consortium for Brain Mapping (ICBM). Philos Trans R Soc Lond B Biol Sci. 2001;356:1293\u2013322.","journal-title":"Philos Trans R Soc Lond B Biol Sci"},{"key":"3928_CR66","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.neuroimage.2003.10.051","volume":"22","author":"C Mulert","year":"2004","unstructured":"Mulert C, J\u00e4ger L, Schmitt R, Bussfeld P, Pogarell O, M\u00f6ller H-J, et al. Integration of fMRI and simultaneous EEG: Towards a comprehensive understanding of localization and time-course of brain activity in target detection. Neuroimage. 2004;22:83\u201394.","journal-title":"Neuroimage"},{"key":"3928_CR67","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1002\/hbm.10038","volume":"17","author":"D Vitacco","year":"2002","unstructured":"Vitacco D, Brandeis D, Pascual-Marqui R, Martin E. Correspondence of event-related potential tomography and functional magnetic resonance imaging during language processing. Hum Brain Mapp. 2002;17:4\u201312.","journal-title":"Hum Brain Mapp"},{"key":"3928_CR68","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1023\/A:1023407521772","volume":"12","author":"GA Worrell","year":"2000","unstructured":"Worrell GA, Lagerlund TD, Sharbrough FW, Brinkmann BH, Busacker NE, Cicora KM, et al. Localization of the epileptic focus by low-resolution electromagnetic tomography in patients with a lesion demonstrated by MRI. Brain Topogr. 2000;12:273\u201382.","journal-title":"Brain Topogr"},{"key":"3928_CR69","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1016\/j.neuroimage.2016.11.001","volume":"147","author":"L Cao","year":"2017","unstructured":"Cao L, Thut G, Gross J. The role of brain oscillations in predicting self-generated sounds. Neuroimage. 2017;147:895\u2013903.","journal-title":"Neuroimage"},{"key":"3928_CR70","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1016\/j.neuroimage.2015.07.055","volume":"122","author":"H-RM Tan","year":"2015","unstructured":"Tan H-RM, Gross J, Uhlhaas PJ. MEG\u2014measured auditory steady-state oscillations show high test\u2013retest reliability: A sensor and source-space analysis. Neuroimage. 2015;122:417\u201326.","journal-title":"Neuroimage"},{"key":"3928_CR71","doi-asserted-by":"publisher","first-page":"4631","DOI":"10.1002\/hbm.23688","volume":"38","author":"Q Liu","year":"2017","unstructured":"Liu Q, Farahibozorg S, Porcaro C, Wenderoth N, Mantini D. Detecting large-scale networks in the human brain using high-density electroencephalography. Hum Brain Mapp. 2017;38:4631\u201343.","journal-title":"Hum Brain Mapp"},{"key":"3928_CR72","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/j.jad.2023.01.126","volume":"328","author":"A Miljevic","year":"2023","unstructured":"Miljevic A, Bailey NW, Murphy OW, Perera MPN, Fitzgerald PB. Alterations in EEG functional connectivity in individuals with depression: A systematic review. J Affect Disord. 2023;328:287\u2013302.","journal-title":"J Affect Disord"},{"key":"3928_CR73","doi-asserted-by":"publisher","first-page":"521","DOI":"10.3389\/fnhum.2018.00521","volume":"12","author":"JJ Newson","year":"2019","unstructured":"Newson JJ, Thiagarajan TC. EEG frequency bands in psychiatric disorders: A review of resting state studies. Front Hum Neurosci. 2019;12:521.","journal-title":"Front Hum Neurosci"},{"key":"3928_CR74","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/hbm.1058","volume":"15","author":"TE Nichols","year":"2002","unstructured":"Nichols TE, Holmes AP. Nonparametric permutation tests for functional neuroimaging: A primer with examples. Hum Brain Mapp. 2002;15:1\u201325.","journal-title":"Hum Brain Mapp"},{"key":"3928_CR75","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1097\/00004647-199601000-00002","volume":"16","author":"AP Holmes","year":"1996","unstructured":"Holmes AP, Blair RC, Watson JDG, Ford I. Nonparametric analysis of statistic images from functional mapping experiments. J Cereb Blood Flow Metab. 1996;16:7\u201322.","journal-title":"J Cereb Blood Flow Metab"},{"key":"3928_CR76","unstructured":"R Core Team. R: A language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria. https:\/\/www.R-project.org\/. 2025."},{"key":"3928_CR77","unstructured":"Posit team. RStudio: Integrated Development Environment for R. Posit Software PBC, Boston, USA. https:\/\/www.posit.co\/ 2025."},{"key":"3928_CR78","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1002\/hbm.23341","volume":"38","author":"D Vatansever","year":"2017","unstructured":"Vatansever D, Manktelow AE, Sahakian BJ, Menon DK, Stamatakis EA. Angular default mode network connectivity across working memory load. Hum Brain Mapp. 2017;38:41\u201352.","journal-title":"Hum Brain Mapp"},{"key":"3928_CR79","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1007\/s00429-022-02569-9","volume":"228","author":"T Mizrahi","year":"2023","unstructured":"Mizrahi T, Axelrod V. Similarity in activity and laterality patterns in the angular gyrus during autobiographical memory retrieval and self-referential processing. Brain Struct Funct. 2023;228:219\u201338.","journal-title":"Brain Struct Funct"},{"key":"3928_CR80","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1038\/s41562-017-0244-9","volume":"1","author":"V Axelrod","year":"2017","unstructured":"Axelrod V, Rees G, Bar M. The default network and the combination of cognitive processes that mediate self-generated thought. Nat Hum Behav. 2017;1:896\u2013910.","journal-title":"Nat Hum Behav"},{"key":"3928_CR81","first-page":"eaat8078","volume":"364","author":"RN Moda-Sava","year":"2019","unstructured":"Moda-Sava RN, Murdock MH, Parekh PK, Fetcho RN, Huang BS, Huynh TN, et al. Sustained rescue of prefrontal circuit dysfunction by antidepressant-induced spine formation. Science (1979). 2019;364:eaat8078.","journal-title":"Science (1979)"},{"key":"3928_CR82","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1001\/archpsyc.63.8.856","volume":"63","author":"CA Zarate","year":"2006","unstructured":"Zarate CA, Singh JB, Carlson PJ, Brutsche NE, Ameli R, Luckenbaugh DA, et al. A randomized trial of an N-methyl-D-aspartate Antagonist in treatment-resistant major depression. Arch Gen Psychiatry. 2006;63:856.","journal-title":"Arch Gen Psychiatry"},{"key":"3928_CR83","doi-asserted-by":"publisher","first-page":"1526","DOI":"10.1038\/npp.2011.338","volume":"37","author":"L Ibrahim","year":"2012","unstructured":"Ibrahim L, DiazGranados N, Franco-Chaves J, Brutsche N, Henter ID, Kronstein P, et al. Course of improvement in depressive symptoms to a single intravenous infusion of ketamine vs add-on riluzole: Results from a 4-Week, double-blind, placebo-controlled study. Neuropsychopharmacology. 2012;37:1526\u201333.","journal-title":"Neuropsychopharmacology"},{"key":"3928_CR84","doi-asserted-by":"publisher","first-page":"444","DOI":"10.2174\/1570159X12666140619204251","volume":"12","author":"G Serafini","year":"2014","unstructured":"Serafini G, Howland R, Rovedi F, Girardi P, Amore M. The role of ketamine in treatment-resistant depression: A systematic review. Curr Neuropharmacol. 2014;12:444\u201361.","journal-title":"Curr Neuropharmacol"},{"key":"3928_CR85","doi-asserted-by":"publisher","first-page":"19r12889","DOI":"10.4088\/JCP.19r12889","volume":"81","author":"GI Papakostas","year":"2020","unstructured":"Papakostas GI, Salloum NC, Hock RS, Jha MK, Murrough JW, Mathew SJ, et al. Efficacy of esketamine augmentation in major depressive disorder. J Clin Psychiatry. 2020;81:19r12889.","journal-title":"J Clin Psychiatry"},{"key":"3928_CR86","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1038\/s41386-024-01901-7","volume":"50","author":"NG Harnett","year":"2025","unstructured":"Harnett NG, Merrill LC, Fani N. Racial and ethnic socioenvironmental inequity and neuroimaging in psychiatry: A brief review of the past and recommendations for the future. Neuropsychopharmacology. 2025;50:3\u201315.","journal-title":"Neuropsychopharmacology"},{"key":"3928_CR87","doi-asserted-by":"publisher","first-page":"405","DOI":"10.9758\/cpn.23.1138","volume":"22","author":"PJ Fitzgerald","year":"2024","unstructured":"Fitzgerald PJ. Frontal alpha asymmetry and its modulation by monoaminergic neurotransmitters in depression. Clin Psychopharmacol Neurosci. 2024;22:405\u201315.","journal-title":"Clin Psychopharmacol Neurosci"}],"container-title":["Translational Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41398-026-03928-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41398-026-03928-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41398-026-03928-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T09:02:59Z","timestamp":1773219779000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41398-026-03928-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,6]]},"references-count":87,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["3928"],"URL":"https:\/\/doi.org\/10.1038\/s41398-026-03928-4","relation":{},"ISSN":["2158-3188"],"issn-type":[{"value":"2158-3188","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,6]]},"assertion":[{"value":"8 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 February 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 February 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 March 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Over the past 3 years, Dr. Pizzagalli has received consulting fees from Abbvie, Arrowhead Pharmaceuticals, Boehringer Ingelheim, Circular Genomics, Compass Pathways, Engrail Therapeutics, N1 Biocorp Inc, Neumora Therapeutics, Neurocrine Biosciences, Neuroscience Software, Takeda, TP Sciences, and Xenon Pharmaceuticals; he has received honoraria from the American Psychological Association, Psychonomic Society and Springer (for editorial work) and Alkermes; he has received research funding from the Bird Foundation, Brain and Behavior Research Foundation, Circular Genomics, Dana Foundation, Millennium Pharmaceuticals, NIMH, and Wellcome Leap; he has received stock options from Ceretype Neuromedicine, Compass Pathways, Engrail Therapeutics, Neumora Therapeutics, and Neuroscience Software. All other authors have no conflicts of interest or relevant disclosures. All views expressed are solely those of the authors.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"134"}}